[Hopespringpcsg] FW: ASCO GU: Enzalutamide Delays Metastasis in Castration-ResistantProstate Cancer

[Glen Tolhurst]

Hi all:
Interesting article below.
Thx.
Glen

Sent from Mail for Windows 10

From: Cancer Network
Sent: February 9, 2018 3:32 PM
To: glen46nor at gmail.com
Subject: ASCO GU: Enzalutamide Delays Metastasis in Castration-ResistantProstate Cancer

Clinical model predicts survival for atezolizumab in bladder cancer
To view this email as a web page, click here.




ASCO GU 2018   |  February 9, 2018 
  
Enzalutamide Delays Metastasis in Castration-Resistant Prostate Cancer 
Enzalutamide resulted in a 71% reduction in metastatic disease risk among men with castration-resistant prostate cancer and rapid prostate-specific antigen doubling time, according to the first interim analysis of data from the phase III PROSPER trial. 
 Read more  
ADVERTISEMENT 


  
Clinical Model Predicts Survival for Atezolizumab in Bladder Cancer 
A newly developed clinical model can predict overall survival for patients diagnosed with advanced bladder cancer who are treated with atezolizumab.

 Read more  


  
Could Experimental Gene Signature Predict Prostate Cancer Recurrence? 
Researchers are developing a prognostic hypoxia gene signature for patients with localized prostate cancer treated with prostatectomy that predicts biochemical failure and metastasis.

 Read more  


  

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: UBM Medica, a division of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
NEWSLETTER
Forward to a Friend 
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Subscribe to Print
Contact Us 
CONNECT
      


  

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20180210/4b59f9b7/attachment-0001.html>